Bullish & Foolish
Full CURX fundamentals All 466 on the Survival Watch

CURXCuranex Pharmaceuticals Inc

Is Curanex Pharmaceuticals struggling financially?

Yes, by its own account. Curanex Pharmaceuticals told the SEC on 14 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$7.4M
Source filing
10-Q 14 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 2months

    If the burn speeds up

    Empty by Aug 2026

  • 4months

    If it eases off

    Empty by Oct 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$2.9M

÷

Cash burned over the last 12 months

$13.5M

What Curanex Pharmaceuticals told the SEC

…budgets, expected profitability, investment and financing activities, and strategic planning. In prior years, the Company disclosed conditions that raised substantial doubt about its ability to continue as a going concern. Management has re-evaluated the Company’s liquidity and capital resources for the twelve-month period from the date of issuance of these unaudited interim financial statements. While…

Curanex Pharmaceuticals Inc, Form 10-Q, filed 14 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 18.1% share-count increase The company issued stock. Each share now owns 15.4% less of the business than a year ago, before any change in the price.

Other Biotech/Pharma companies that filed the doubt